MAP Pharmaceuticals

MAP Pharma shares dive after FDA rejects migraine drug
Reuters
Tue, 03/27/12 - 09:15 am
FDA
migraines
MAP Pharmaceuticals
Front-Month Put Volume Rises on MAP Pharmaceuticals
Schaeffer's Research
Sat, 03/24/12 - 01:19 pm
MAP Pharmaceuticals
FDA likely to make announcement on key MAP drug Monday
The Fly on the Wall
Fri, 03/23/12 - 12:17 pm
Levadex
FDA
MAP Pharmaceuticals
migraines
MAP Pharma: Making Money From Migraines
Seeking Alpha
Sun, 03/11/12 - 12:09 pm
MAP Pharmaceuticals
Levadex
migraines
Pain-Wracked Migraine Patients’ Unmet Needs Targeted by Map’s Inhaled Drug
Bloomberg
Tue, 03/6/12 - 11:05 am
MAP Pharmaceuticals
migraines
DHE
Levadex
MAP Pharmaceuticals Issued Additional U.S. Patent for Methods of Achieving Rapid Treatment of Migraine Based Upon Pharmacokinetic Profile
Yahoo
Thu, 02/23/12 - 10:35 am
migraines
MAP Pharmaceuticals
patents
Small Pharma With Big Compounds: Final Dance With The FDA
Seeking Alpha
Mon, 02/6/12 - 09:42 am
GSK
AstraZeneca
FDA
Eli Lilly
Pfizer
Vivus
Merck
MAP Pharmaceuticals
Buying Map Pharmaceuticals Ahead Of FDA Decision
Seeking Alpha
Mon, 01/30/12 - 12:05 pm
FDA
MAP Pharmaceuticals
migraines
Levadex
MAP's Levadex: Blockbuster Potential With A March 26 PDUFA Date
Seeking Alpha
Thu, 12/15/11 - 09:39 am
Levadex
MAP Pharmaceuticals
FDA
migraines
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
MAP Pharma gets US patent for methods of achieving rapid relief of migraine and minimizing side effects based upon pharmacokinetic profile
Pharmabiz
Sun, 08/14/11 - 11:32 am
MAP Pharmaceuticals
Levadex
migraines
Tempo inhaler
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals
MAP Pharmaceuticals issued migraine treatment patent
Bizjournals.com
Thu, 08/11/11 - 11:14 am
MAP Pharmaceuticals
patents
migraines
MAP Pharmaceuticals Reports Second Quarter of 2011 Financial Results
Yahoo
Thu, 08/4/11 - 10:26 am
MAP Pharmaceuticals
earnings
MAP Pharmaceuticals gets $20M payment for FDA filing
Bizjournals.com
Wed, 08/3/11 - 09:40 am
FDA
MAP Pharmaceuticals
Levadex
migraines
Allergan
MAP Pharmaceuticals looks to FDA for migraine treatment approval
Medreps
Sat, 05/28/11 - 02:02 pm
MAP Pharmaceuticals
Levadex
migraines
MAP Pharma files NDA for migraine drug
Pharmaceutical Business Review
Fri, 05/27/11 - 09:04 am
migraines
MAP Pharmaceuticals
Levadex
Allergan signs agreement with MAP Pharmaceuticals for LEVADEX
Tue, 02/1/11 - 05:15 pm
Allergan
MAP Pharmaceuticals
Levadex
migraines
Allergan and MAP Pharmaceuticals Announce Collaboration on LEVADEX(TM) Investigational Therapy for Acute Migraine
Trading Markets
Mon, 01/31/11 - 08:39 am
Allergan
MAP Pharmaceuticals
Levadex
migraines
MAP reports 3Q loss on lack of revenue
Yahoo/AP
Fri, 11/5/10 - 12:18 pm
earnings
MAP Pharmaceuticals

Pages